Home > Healthcare > Medical Devices > Diagnostic Devices > Endoscopy Market
Endoscopy Market size was worth USD 36.9 billion in 2022 and is poised to observe 6.8% CAGR from 2023-2032, driven by the increasing demand for endoscopy procedures among the rapidly expanding geriatric population.
The rising vulnerability of the geriatric individuals to chronic illnesses, such as orthopedic, gastrointestinal, ophthalmology, and cancer due to decreased immunity and deteriorating health will drive the market growth. To that end, a large number of medical device manufacturers are developing medically sophisticated technologies to meet the rising requirements for minimally invasive surgical treatments conducted in safe and efficient manner. For instance, in May 2023, the Olympus Corporation gained the FDA certification for the EVIS X1 endoscopic system, which includes two interchangeable gastrointestinal endoscopes.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Endoscopy Market Size in 2022: | USD 36.9 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 6.8% |
2032 Value Projection: | USD 72 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 205 |
Tables, Charts & Figures: | 266 |
Segments covered: | Product, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The shortage of skilled physicians and endoscopists in developing countries may limit the endoscopy market growth to some extent. While the demand for endoscopic procedures is rising due to their minimally invasive nature and diagnostic accuracy, the availability of trained professionals to perform these procedures is limited. Hence, multiple challenges in providing comprehensive medical training and specialization programs are leading to the scarcity of qualified endoscopy practitioners. The declining adoption of advanced endoscopic techniques along with the hindered patient access to timely and accurate diagnoses are also likely to negatively impact the market revenue.
The COVID-19 pandemic made way for global health emergency, affecting both the industrial and healthcare sectors. Many governments throughout the world implemented statewide lockdowns to prevent the virus from spreading. Medical treatments, such as pulmonary and gynecological endoscopic operations, were also delayed in various nations, leading to restricted visits to healthcare institutions. However, with the number of cases stabilizing, the market is set to witness remarkable expansion in the post-pandemic period.
The rapid advancement of robotic-assisted endoscopy is the major trend augmenting the market outlook. Robotic systems are increasingly integrated into endoscopic procedures for enhancing the precision, control, and maneuverability in complex surgeries and diagnostic interventions. These systems offer surgeons enhanced dexterity and 3D view of the surgical site, enabling minimally invasive techniques in challenging anatomical areas. The surging popularity of robotic-assisted endoscopy to improve patient outcomes by reducing trauma, post-operative pain, and recovery time will also favor the industry expansion.
Endoscopy market from the endoscopes segment accounted for 50% share in 2022 and is expected to witness robust growth through 2032. The growth can be attributed to the rising technical improvements leading to the emergence of novel endoscopic equipment. The surging spending on healthcare for superior infrastructure, along with the growing innovations by multiple industry participants will outline the industry expansion. For instance, in November 2021, Medtronic PLC, by combining Amazon logistics, unveiled Pillcam SB3 at HOME, a capsule endoscopy product for providing accurate and timely results conveniently at home.
The hospital end-use segment in the endoscopy market is projected to reach USD 37.2 billion by 2032. The surging adoption of endoscopic procedures for diagnosis and minimally invasive surgeries is driving the segment growth. Moreover, the rising focus of hospitals and healthcare institutions on minimizing patient wait times have led to major investments to increase patient access to diagnostic imaging, such as endoscopy. For instance, in September 2022, Torbay Hospital benefitted from a £4.99 million capital investment to boost capacity and assist in cutting the local waiting lists for endoscopy services.
North America endoscopy market size is expected to be valued at USD 28.6 billion by 2032 due to the presence of major industry players as well as the rapidly increasing older population. The high prevalence of stomach cancer among Americans is one of the main reasons for abdominal pain, further driving the preference for endoscopy. For instance, over 26,000 new cases of stomach cancer were recorded in the U.S. in 2021, leading to more than 11,000 fatalities, according to data released by the American Cancer Society. The rising number of endoscopic procedures mainly in the U.S. will thereby boost the industry development.
The competitive landscape of the endoscopy market includes; prominent companies such as
Click here to Buy Section of this Report
By Product, 2018 - 2032 (USD Million)
By Application, 2018 - 2032 (USD Million)
By End-use, 2018 - 2032 (USD Million)
The above information is provided for the following regions and countries: